Capital Social Ordinario Cambio Fecha
Arca Biopharma USD 50.17M 1.45M 2026-03
Bio Path USD 9.34M 100K 2026-03
Bioline Rx USD 2.62B 10.16M 2026-06
Capricor Therapeutics USD 57.37M 11.65M 2025-12